COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent
- PMID: 34453892
- PMCID: PMC8384757
- DOI: 10.1053/j.gastro.2021.08.037
COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent
Comment on
-
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.Gastroenterology. 2021 Nov;161(5):1487-1501.e5. doi: 10.1053/j.gastro.2021.07.010. Epub 2021 Jul 18. Gastroenterology. 2021. PMID: 34284037 Free PMC article.
Similar articles
-
Correspondence on "prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection".Ann Hepatol. 2021 Nov-Dec;25:100360. doi: 10.1016/j.aohep.2021.100360. Epub 2021 Jun 10. Ann Hepatol. 2021. PMID: 34119682 Free PMC article. No abstract available.
-
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).Hepatol Int. 2020 Sep;14(5):690-700. doi: 10.1007/s12072-020-10072-8. Epub 2020 Jul 4. Hepatol Int. 2020. PMID: 32623632 Free PMC article.
-
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19.Gut. 2021 Sep;70(9):1798-1799. doi: 10.1136/gutjnl-2020-322929. Epub 2020 Oct 7. Gut. 2021. PMID: 33028665 No abstract available.
-
SARS-CoV-2 infection in patients with a normal or abnormal liver.J Viral Hepat. 2021 Jan;28(1):4-11. doi: 10.1111/jvh.13440. Epub 2020 Dec 1. J Viral Hepat. 2021. PMID: 33190321 Free PMC article. Review.
-
ACE2: from protection of liver disease to propagation of COVID-19.Clin Sci (Lond). 2020 Dec 11;134(23):3137-3158. doi: 10.1042/CS20201268. Clin Sci (Lond). 2020. PMID: 33284956 Review.
Cited by
-
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212. Int J Mol Sci. 2024. PMID: 38396888 Free PMC article. Review.
-
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.Infect Dis Poverty. 2022 May 16;11(1):56. doi: 10.1186/s40249-022-00982-0. Infect Dis Poverty. 2022. PMID: 35578350 Free PMC article.
-
Liver injury in COVID-19: A minireview.World J Gastroenterol. 2022 Dec 21;28(47):6716-6731. doi: 10.3748/wjg.v28.i47.6716. World J Gastroenterol. 2022. PMID: 36620342 Free PMC article. Review.
-
Evaluation of the effects of the pandemic period on cirrhosis patients.Prz Gastroenterol. 2023;18(3):320-326. doi: 10.5114/pg.2023.131393. Epub 2023 Sep 22. Prz Gastroenterol. 2023. PMID: 37937105 Free PMC article.
-
Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.Medicina (Kaunas). 2022 Dec 28;59(1):62. doi: 10.3390/medicina59010062. Medicina (Kaunas). 2022. PMID: 36676691 Free PMC article. Review.
References
-
- Coronavirus Resource Center Johns Hopkins University of Medicine. https://coronavirus.jhu.edu Available at: Accessed July 30, 2021.
-
- Albillos A., Lario M., Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61:1385–1396. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical